The Technical and Laboratory team at Cygnus Technologies, LLC is responsible for conducting critical bioprocess impurity detection and viral clearance assays, utilizing proprietary technologies such as Antibody Affinity Extraction™ (AAE) and Mass Spectrometry. This team supports biopharmaceutical companies by providing high-quality analytical tools and solutions that ensure the safety of therapeutic proteins, vaccines, antibodies, plasma derivatives, and gene therapies. Their expertise aids in advancing bioprocess development, ensuring faster regulatory approval, and improving clinical outcomes. The team also handles the preparation, execution, and fulfillment of assay orders, maintaining the company's standards of operational excellence and quality management.
View all